Prognosis after surgery for multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: Functionality matters.
Fiche publication
Date publication
novembre 2020
Journal
Surgery
Auteurs
Membres identifiés du Cancéropôle Est :
Dr GOUDET Pierre
Tous les auteurs :
van Beek DJ, Nell S, Verkooijen HM, Borel Rinkes IHM, Valk GD, , Vriens MR, , Goudet P, , Santucci N, Bartsch DK, Manoharan J, Perrier ND, Zagzag J, Brandi ML, Giusti F, Nilubol N, Brunaud L, Pasternak JD, Hsiao R, Sturgeon C, Giri S, Conemans EB, Brosens LA, , Bonsing BA, van Eijck CH, van Goor H, de Kleine RHJ, Nieveen van Dijkum EJ, Kazemier G, Dejong CHC
Lien Pubmed
Résumé
Metastasized pancreatic neuroendocrine tumors are the leading cause of death in patients with multiple endocrine neoplasia type 1. Aside from tumor size, prognostic factors of pancreatic neuroendocrine tumors are largely unknown. The present study aimed to assess whether the prognosis of patients with resected multiple endocrine neoplasia type 1-related nonfunctioning pancreatic neuroendocrine tumors differs from those with resected multiple endocrine neoplasia type 1-related insulinomas and assessed factors associated with prognosis.
Référence
Surgery. 2020 Nov 18;: